X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Tags:
Preliminary data from the Pfizer, BioNTech Phase 1 mRNA COVID-19 vaccine trials are showing promise, according to the University of Maryland School of Medicine. ... [Read More]
Two out of four of Pfizer's coronavirus vaccine candidates, BNT162b1 and BNT162b2, have been granted the 'fast track' designation by the FDA. [Read More]
The "Transcatheter Embolization and Occlusion Devices - Global Market Outlook (2019 -2027)" report has been added to ResearchAndMarkets.com's... [Read More]
This move comes after the two companies released early data at the beginning of the month, showing promising results. [Read More]
Pfizer Inc. (NYSE PFE) and BioNTech SE (Nasdaq BNTX, BioNTech ) today announced that two of the companies four investigational vaccine candidates from their BNT... [Read More]
Pfizer, which has manufacturing facilities in Michigan, gets "fast track" status for two of four coronavirus vaccines the company is developing. [Read More]
Thumbnail
Pfizer's (PFE) shares jump after FDA grants fast track status to two coronavirus vaccine candidates... [Read More]
Two experimental coronavirus vaccines, manufactured jointly by Pfizer and BioNTech, have received fast track status from the FDA. [Read More]
U.S. stock futures moved higher in overnight trade following a stunning reversal on Monday as California rolled back its reopening plans, triggering worries about another... [Read More]
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent. [Read More]
The U.S.-listed shares of the German firm climbed about 10%, while Pfizer's stock rose about 2% before the bell. [Read More]
We expect no-moat BioNTech and wide-moat Pfizer to move one of the test candidates into the next phase, planned to start as early as this... [Read More]
California Gov. Gavin Newsom rolls back state's reopening plans. Pfizer, BioNTech get fast-track approval for coronavirus vaccine candidate. Maxim Integrated shares jump on... [Read More]
Stocks that moved heavily or traded substantially on Monday: Analog Devices, AMC fall; Pfizer, Quest Diagnostics rise... [Read More]
The companies expect to manufacture 100 million doses by the end of 2021. [Read More]
Stocks closed mostly lower Monday, with the Dow clinging to a modest gain, after technology stocks fell and rising coronavirus cases led California's governor to... [Read More]
US Food and Drug Administration officials granted fast track status to two shots being made by Pfizer and partner BioNTech, a designation that will speed... [Read More]
Led by strong returns for shares of Pfizer and UnitedHealth, the Dow Jones Industrial Average is climbing Monday afternoon. The Dow is trading 28 points,... [Read More]
Healthcare is the rare leader today, but is still looking for a breakout moment.The SPDR Select Sector Healthcare ETF (NYSEARCA:XLV) is up about 1.2% in... [Read More]
Loading...
Save As
Preview
Preview